On Sept. 23, investment management firm Invesco—the company behind the enormously popular Invesco QQQ Trust Series 1 NASDAQ: QQQ and its sister fund, the Invesco NASDAQ 100 ETF NASDAQ: QQQM—launched the newest member of its Q-themed offerings: Invesco Nasdaq International Innovators 100 ETF NASDAQ: QQI.
This new ETF builds upon QQQ’s track record.
For more than 25 years, that fund—which now boasts more than $485 billion in assets under management (AUM)—has provided growth-focused investors with access to some of the market's most innovative companies all in one basket.
However, while the QQQ and QQQM track the Nasdaq-100 Index and the 100 largest nonfinancial companies listed on the Nasdaq, many of which are U.S.-domiciled firms, Invesco’s newest fund provides exposure to often-overlooked international growth stocks.
Invesco’s Expansion Into Global Growth Innovators
Invesco Nasdaq International Innovators 100 ETF Today
QQI
Invesco Nasdaq International Innovators 100 ETF
$24.50 +0.04 (+0.16%) As of 10/23/2026 03:23 PM Eastern
- 52-Week Range
- $24.39
▼
$27.66
The QQI expands the Invesco QQQ Innovation Suite with a global slant.
The fund is composed of large- and mid-cap companies that span developed and emerging markets and which are identified by Nasdaq as innovators.
QQI seeks to replicate, as closely as possible, the performance of the Nasdaq International Innovators 100 Index, which tracks companies headquartered outside the United States.
Specifically, the index comprises firms that demonstrate innovative characteristics, including significant research and development (R&D) expenditures, revenue growth, gross margin growth and measures of sustained profitability capable of altering the global economy.
Those core tenets build upon other means of identifying innovators that go beyond many of the rear-facing metrics that are often used to identify innovators, like earnings per share trends and long-term sales growth. The Nasdaq International Innovators 100 Index screens for five metrics organized around three innovation-based concepts:
Intentional investment in innovation: The index measures a company’s R&D expense as a percentage of annual sales, which indicates a company’s commitment to R&D as part of its corporate strategy.
Commercialization of R&D: The index calculates revenue growth and gross margin growth to identify companies that have successfully translated R&D spending into measurable business results.
Durable competitive positioning: The index computes three-year average gross margin and the three-year gross margin Sharpe ratio to help identify companies with sustained profitability over time.
For context, companies in the MSCI ACWI ex USA Index and the developed markets-focused MSCI EAFE Growth Index spend approximately 5% of annual sales on R&D, while those in the broader MSCI EAFE Index spend around 3%. By comparison, companies in the Nasdaq International Innovators 100 Index devote approximately 13% of sales to R&D.
According to Invesco, “these measures help separate companies that have merely benefited from past growth from those actively investing in innovation and turning that investment into business performance.”
For investors, the approach offers international growth exposure that emphasizes not just innovation spending, but a company's ability to translate that investment into profitable growth.
QQI’s Diverse Basket of Global Innovators
If QQI sounds like an ETF that would carry a heavy bias toward tech, that’s because it does. Currently, 42% of the fund’s portfolio is allocated to that sector. But QQI also includes significant allocations to healthcare (24.1%), industrials (8.8%), and consumer discretionary (7.1%).
QQI’s holdings are also geographically diverse, providing exposure to companies across developed and emerging markets, including Taiwan, China, Japan, South Korea, and several European countries. That geographic reach gives investors access to innovation beyond the United States, although the fund remains heavily concentrated in technology and other growth-oriented industries.
Among its top holdings, the fund—which nearly a month after its debut has $3.91 million in AUM—has a handful of household names that are familiar to growth investors. Taiwan Semiconductor Manufacturing NYSE: TSM is the ETF’s largest position at 10.34% of the portfolio, followed by ASML Holding N.V. NASDAQ: ASML at 5.63%, SK hynix NASDAQ: SKHY at 4.59%, Roche Holding AG OTCMKTS: RHHBY at 4.24%, and Tencent Holdings Ltd. OTCMKTS: TCEHY at 3.82%.
The Fund’s Potential Upside Could Come With Growing Pains
As a new fund, QQI's biggest concern is liquidity. Average daily volume stands at less than 11,500 shares. By comparison, QQQ sees an average of 47.88 million shares change hands daily. That difference could translate into wider bid-ask spreads and higher trading costs for QQI investors.
Another risk is volatility. Amid the current AI sell-off, ETFs that track tech-heavy indices could face increased selling pressure. While QQI is too new to measure, QQQ and QQQM both sport betas of 1.22, meaning they are 22% more volatile than the broad S&P 500. QQI’s focus on international stocks in developed and emerging markets introduces currency and geopolitical risks, increasing the likelihood that its beta will be higher than that of its Invesco counterparts.
Lastly, with a net expense ratio of 0.29%, the fund is more expensive than QQQ (0.18%) and QQQM (0.15%). But for investors looking to maintain growth exposure while diversifying away from potential concentration among U.S. innovators, QQI could provide an ideal fit.
Before you consider Invesco Nasdaq International Innovators 100 ETF, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Invesco Nasdaq International Innovators 100 ETF wasn't on the list.
While Invesco Nasdaq International Innovators 100 ETF currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.